Post by account_disabled on Dec 19, 2023 17:25:35 GMT 10
APCO prepares to pay dividends of 0.1234 baht/share, equivalent to 100% for 11 consecutive years, elevating the operations of the immunotherapy business. To become a leader in stimulating killer T cells (Killer T Cell), preparing to establish KILLER T CELL Company Limited to expand innovation both domestically and abroad. Ready to establish an HIV treatment center in collaboration with medical institutions. Aiming to expand product base to pet lovers group Targeting domestic sales growth of 50%, maintaining gross profit margin of not less than 80%, revealing 2021 operating results, total income of 226.38 million baht, net profit of 68.70 million baht. Prof. Dr. Pichet Wiriyachitra, Chief Executive Officer of Asian Phytoceuticals Public Company Limited or APCO, owner of a
natural innovation business for health and beauty with Phone Number List integrated research, development, production and distribution, revealed that The Board of Directors' meeting resolved to approve paying dividends to shareholders at the rate of 0.1234 baht per share, or 100% of net profits, which marks the 11th year that the company has paid dividends to shareholders at the rate of 100% continuously. The dividend will be paid in cash, totaling 74.04 million baht. The list of shareholders who have the right to receive dividends (Record Date) is set for 27 April 2022 and the dividend will be paid on 9 May 2022 (request approval from Shareholder meeting on 18 April 2022) In addition,
the Executive Committee acknowledged the progress in business operations using Killer T Cells to deal with widespread cancer problems. and managed HIV until the infected person was undetectable without using antiretroviral drugs successfully for the first time in the world and announcement of success on World AIDS Day, 1 December 2021, by the Prime Minister and Minister of Health Sent a representative to attend. To be considered for the benefit of the Thai population in the future. Ready to approve the establishment KILLER T CELL CO., LTD. to conduct business specifically for this purpose. Those interested can set up a joint company. To bring this innovation to distribute both domestically and abroad. To treat all types of viral, fungal, and bacterial infections. and cancer symptoms at every stage Killer T Cell Therapy for HIV Center in collaboration with medical institutions in Thailand By allowing
natural innovation business for health and beauty with Phone Number List integrated research, development, production and distribution, revealed that The Board of Directors' meeting resolved to approve paying dividends to shareholders at the rate of 0.1234 baht per share, or 100% of net profits, which marks the 11th year that the company has paid dividends to shareholders at the rate of 100% continuously. The dividend will be paid in cash, totaling 74.04 million baht. The list of shareholders who have the right to receive dividends (Record Date) is set for 27 April 2022 and the dividend will be paid on 9 May 2022 (request approval from Shareholder meeting on 18 April 2022) In addition,
the Executive Committee acknowledged the progress in business operations using Killer T Cells to deal with widespread cancer problems. and managed HIV until the infected person was undetectable without using antiretroviral drugs successfully for the first time in the world and announcement of success on World AIDS Day, 1 December 2021, by the Prime Minister and Minister of Health Sent a representative to attend. To be considered for the benefit of the Thai population in the future. Ready to approve the establishment KILLER T CELL CO., LTD. to conduct business specifically for this purpose. Those interested can set up a joint company. To bring this innovation to distribute both domestically and abroad. To treat all types of viral, fungal, and bacterial infections. and cancer symptoms at every stage Killer T Cell Therapy for HIV Center in collaboration with medical institutions in Thailand By allowing